ProShare Advisors LLC Q4 2021 Filing

Filed February 8, 2022

Portfolio Value

$51.0B

Holdings

2,338

Report Date

Q4 2021

Filing Type

13F-HR

All Holdings (2,338 positions)

StockValue
ALDXALDEYRA THERAPEUTICS INC
$43K
CASTLIGHT HEALTH INC
$42K
FORTRESS BIOTECH INC
$41K
ATOSEURATOSSA THERAPEUTICS INC
$41K
ATHERSYS INC NEW
$40K
LPTXEURLEAP THERAPEUTICS INC
$40K
PAVMED INC
$40K
0KB2HUMANIGEN INC
$40K
BHGBRIGHT HEALTH GROUP INC
$40K
ADMAADMA BIOLOGICS INC
$39K
PBYIPUMA BIOTECHNOLOGY INC
$39K
HCHCEURINNOVATE CORP
$38K
CTXRCITIUS PHARMACEUTICALS INC
$38K
NAGECHROMADEX CORP
$38K
NCMIEURNATIONAL CINEMEDIA INC
$37K
CARLOTZ INC
$36K
VIRNETX HLDG CORP
$36K
LTRPAUSDLIBERTY TRIPADVISOR HLDGS IN
$35K
SEELOS THERAPEUTICS INC
$35K
N1KNEWAGE INC
$31K
ASPIRA WOMENS HEALTH INC
$27K
ONSGBPOUTLOOK THERAPEUTICS INC
$26K
IBIO INC
$25K
MREOMEREO BIOPHARMA GROUP PLC
$25K
DSEURDRIVE SHACK INC
$25K
ABTUGBXAQUABOUNTY TECHNOLOGIES INC
$24K
AMPIO PHARMACEUTICALS INC
$24K
UAVSAGEAGLE AERIAL SYS INC NEW
$23K
OBSEVA SA
$22K
AVALO THERAPEUTICS INC
$22K
ARDXARDELYX INC
$22K
TREVENA INC
$20K
OPTNOPTINOSE INC
$19K
HALL OF FAME RESORT & ENTMT
$18K
SOC TELEMED INC
$17K
LIVXEURLIVEONE INC
$17K
MARRONE BIO INNOVATIONS INC
$15K
KALAKALA PHARMACEUTICALS INC
$12K
PreviousPage 24 of 24